Genome-wide pathway analysis in amyotrophic lateral sclerosis

Area of Science:

• Genetics
• Neuroscience
• Molecular Biology

Background:

• Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease with complex genetic underpinnings.
• Genome-wide association studies (GWAS) have identified some genetic risk factors, but many cases remain unexplained.

Purpose of the Study:

• To identify candidate single-nucleotide polymorphisms (SNPs) and biological mechanisms associated with ALS.
• To generate hypotheses linking SNPs to genes and pathways involved in ALS pathogenesis.

Main Methods:

• Utilized a GWAS dataset of 276 ALS patients and 271 controls of European descent.
• Applied Identify Candidate Causal SNPs and Pathway (ICSNPathway) analysis to the GWAS data.

Main Results:

• Identified 19 candidate SNPs, 8 genes, and 9 pathways potentially implicated in ALS.
• The strongest hypothetical mechanism involved rs9352 affecting chromatin assembly factor 1 subunit A in chromatin and nucleosome assembly pathways.
• Other significant findings included associations of rs1046329 with HILS1 and rs11100790 with SMARCA5, both related to chromatin assembly.

Conclusions:

• ICSNPathway analysis successfully identified candidate SNPs, pathways, and biological mechanisms contributing to ALS susceptibility.
• These findings provide a foundation for further investigation into the genetic and molecular basis of ALS.